Ceo2-azacrown conjugate as a nanoplatform for combined radiopharmaceuticals

HIGHLIGHTS

  • who: Sofia Khabirova and collaborators from the Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, , Moscow, Russia have published the article: CeO2-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals, in the Journal: Nanomaterials 2022, 12, 4484. of /2022/
  • what: This experiment can partially simulate the behavior of a potential radiopharmaceutical when it is introduced into a living organism and then circulated in the blood.
  • future: Modifying the surface of these particles with bifunctional chelators could open new perspectives and expand the number of radionuclides that can potentially be used.
 

Logo ScioWire Beta black

If you want to have access to all the content you need to log in!

Thanks :)

If you don't have an account, you can create one here.

 

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?